|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 12 (June 15), 2000:
pp. 3915-3921
Constitutive activation of transcription factor AP-1 in primary
adult T-cell leukemia cells
Naoki Mori,
Masahiro Fujii,
Kousuke Iwai,
Shuichi Ikeda,
Yoshihiro Yamasaki,
Tomoko Hata,
Yasuaki Yamada,
Yuetsu Tanaka,
Masao Tomonaga, and
Naoki Yamamoto
From the Department of Preventive Medicine and AIDS Research,
Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan;
Department of Laboratory Medicine, Nagasaki University School of
Medicine, Nagasaki, Japan; Department of Hematology, Atomic Disease
Institute, Nagasaki University School of Medicine, Nagasaki, Japan;
Department of Internal Medicine, City of Sasebo General Hospital,
Sasebo, Japan; Department of Internal Medicine, Kokura Memorial
Hospital, Kitakyushu, Japan; Department of Infectious Disease and
Immunology, Okinawa-Asia Research Center of Medical Science, Faculty of
Medicine, University of the Ryukyus, Okinawa, Japan; Department of
Virology, Niigata University School of Medicine, Niigata, Japan.
Human T-cell leukemia virus type-I (HTLV-I) is the etiologic agent
of adult T-cell leukemia (ATL). This study examined the status of the
oncogenic transcription factor AP-1 in leukemic cells freshly isolated
from patients with ATL. Leukemic cells from peripheral blood of all
patients with ATL exhibited constitutive AP-1 DNA binding activity,
whereas mononuclear cells from normal individuals did not. In agreement
with previous studies, HTLV-I transforming protein, Tax, was found to
stimulate the DNA binding activity of AP-1 in a T-cell line. However,
HTLV-I genes, including Tax, were not significantly expressed in
leukemic cells freshly obtained from patients with ATL. Moreover, all
T-cell lines derived from leukemic cells of patients with ATL also
displayed constitutive AP-1 DNA binding activity, but expressed little
Tax protein. Thus, leukemic cells of patients with ATL appear to have
Tax-independent mechanisms that induce AP-1 activity, both in vivo and
in vitro. In antibody supershift experiments, AP-1 in fresh leukemic
cells and ATL-derived cell lines were found to contain JunD.
Consistently, all primary ATL cells and ATL-derived cell lines
expressed high levels of JunD messenger RNA. Our results suggest that
AP-1 is activated in leukemic cells of patients with ATL through a
Tax-independent mechanism and this may play a role in the deregulated
phenotypes of ATL leukemic cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Mizuguchi, H. Asao, T. Hara, M. Higuchi, M. Fujii, and M. Nakamura
Transcriptional Activation of the Interleukin-21 Gene and Its Receptor Gene by Human T-cell Leukemia Virus Type 1 Tax in Human T-cells
J. Biol. Chem.,
September 18, 2009;
284(38):
25501 - 25511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Isono, T. Ohshima, Y. Saeki, J. Matsumoto, M. Hijikata, K. Tanaka, and K. Shimotohno
Human T-cell Leukemia Virus Type 1 HBZ Protein Bypasses the Targeting Function of Ubiquitination
J. Biol. Chem.,
December 5, 2008;
283(49):
34273 - 34282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bellon and C. Nicot
Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
J Natl Cancer Inst,
January 16, 2008;
100(2):
98 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brown, M. Bellon, and C. Nicot
Emodin and DHA potently increase arsenic trioxide interferon-{alpha}-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1
Blood,
February 15, 2007;
109(4):
1653 - 1659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Mesnard, B. Barbeau, and C. Devaux
HBZ, a new important player in the mystery of adult T-cell leukemia
Blood,
December 15, 2006;
108(13):
3979 - 3982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grant, P. Jain, M. Nonnemacher, K. E. Flaig, B. Irish, J. Ahuja, A. Alexaki, T. Alefantis, and B. Wigdahl
AP-1-directed human T cell leukemia virus type 1 viral gene expression during monocytic differentiation
J. Leukoc. Biol.,
September 1, 2006;
80(3):
640 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Peloponese Jr. and K.-T. Jeang
Role for Akt/Protein Kinase B and Activator Protein-1 in Cellular Proliferation Induced by the Human T-cell Leukemia Virus Type 1 Tax Oncoprotein
J. Biol. Chem.,
March 31, 2006;
281(13):
8927 - 8938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Okudaira, M. Tomita, J.-N. Uchihara, T. Matsuda, C. Ishikawa, H. Kawakami, M. Masuda, Y. Tanaka, K. Ohshiro, N. Takasu, et al.
NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-{kappa}B signal pathway.
Mol. Cancer Ther.,
March 1, 2006;
5(3):
704 - 712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Watanabe, T. Ohsugi, M. Shoda, T. Ishida, S. Aizawa, M. Maruyama-Nagai, A. Utsunomiya, S. Koga, Y. Yamada, S. Kamihira, et al.
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-{kappa}B, as a strategy for chemoprevention and therapy of adult T-cell leukemia
Blood,
October 1, 2005;
106(7):
2462 - 2471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mori, T. Matsuda, M. Tadano, T. Kinjo, Y. Yamada, K. Tsukasaki, S. Ikeda, Y. Yamasaki, Y. Tanaka, T. Ohta, et al.
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells
J. Virol.,
May 1, 2004;
78(9):
4582 - 4590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Levy, Y. Izumiya, P. Brunovskis, L. Xia, M. S. Parcells, S. M. Reddy, L. Lee, H.-W. Chen, and H.-J. Kung
Characterization of the Chromosomal Binding Sites and Dimerization Partners of the Viral Oncoprotein Meq in Marek's Disease Virus-Transformed T Cells
J. Virol.,
December 1, 2003;
77(23):
12841 - 12851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Szremska, L. Kenner, E. Weisz, R. G. Ott, E. Passegue, M. Artwohl, M. Freissmuth, R. Stoxreiter, H.-C. Theussl, S. B. Parzer, et al.
JunB inhibits proliferation and transformation in B-lymphoid cells
Blood,
December 1, 2003;
102(12):
4159 - 4165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Basbous, C. Arpin, G. Gaudray, M. Piechaczyk, C. Devaux, and J.-M. Mesnard
The HBZ Factor of Human T-cell Leukemia Virus Type I Dimerizes with Transcription Factors JunB and c-Jun and Modulates Their Transcriptional Activity
J. Biol. Chem.,
October 31, 2003;
278(44):
43620 - 43627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Saitoh, M. Nakayama, H. Nakano, H. Yagita, N. Yamamoto, and S. Yamaoka
TWEAK Induces NF-{kappa}B2 p100 Processing and Long Lasting NF-{kappa}B Activation
J. Biol. Chem.,
September 19, 2003;
278(38):
36005 - 36012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nasr, A. Rosenwald, M. E. El-Sabban, B. Arnulf, P. Zalloua, Y. Lepelletier, F. Bex, O. Hermine, L. Staudt, H. de The, et al.
Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells
Blood,
June 1, 2003;
101(11):
4576 - 4582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Nicolaou, J. M. Teodoridis, H. Park, A. Georgakis, O. C. Farokhzad, E. P. Bottinger, N. Da Silva, P. Rousselot, C. Chomienne, K. Ferenczi, et al.
CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD
Blood,
May 15, 2003;
101(10):
4033 - 4041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Arnulf, A. Villemain, C. Nicot, E. Mordelet, P. Charneau, J. Kersual, Y. Zermati, A. Mauviel, A. Bazarbachi, and O. Hermine
Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis
Blood,
December 1, 2002;
100(12):
4129 - 4138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mori, Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, and M. Fujii
Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells
Blood,
August 13, 2002;
100(5):
1828 - 1834.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|